Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis
Cited by 49
Related Papers
Is It Time to Start Transitioning From 2D to 3D Cell Culture?
|Frontiers in Molecular Biosciences|2020|1.6k
CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling
|Journal of Experimental & Clinical Cancer Research|2020|138
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
|Nature Medicine|2023|76
Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib
|Journal of Hematology & Oncology|2018|62
Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development
|Journal of Experimental & Clinical Cancer Research|2023|57